{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:12:39Z","timestamp":1696403559275},"reference-count":57,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T00:00:00Z","timestamp":1408752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec><jats:label \/><jats:p>Antibody therapy has become standard of care for adult B cell lymphoma patients. It is a potentially less toxic and more targeted approach for lymphoma therapy and should therefore be applied to treat pediatric B cell lymphoma patients as well. In pediatric lymphoma patients, however, clinical experience with monoclonal antibodies is very limited. This is in part due to smaller patient numbers and very good outcome with conventional chemotherapy. In addition, pediatric patient and lymphoma biology differ significantly from that found in adults often precluding extrapolation of the adult experience to children. This review focuses on targeting pediatric B cell lymphoma with monoclonal antibody therapy. The special characteristics of B cell lymphomas found in children are reviewed and six potential new lymphoma target antigens are discussed. Pediatr Blood Cancer 2014;61:2158\u20132163. \u00a9 2014 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.25193","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T21:53:17Z","timestamp":1408830797000},"page":"2158-2163","source":"Crossref","is-referenced-by-count":1,"title":["New targets for antibody therapy of pediatric B cell lymphomas"],"prefix":"10.1002","volume":"61","author":[{"given":"Annelies","family":"van Vuren","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Meyer\u2010Wentrup","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,8,23]]},"reference":[{"key":"e_1_2_7_2_1","volume-title":"SEER cancer statistics review, 1975\u20132010","author":"Howlader N"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036673"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.677534"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2744"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00068"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-136465"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21619"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4213"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00003"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3236"},{"key":"e_1_2_7_14_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow HS","year":"2008"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030809"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00020-0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07393.x"},{"key":"e_1_2_7_18_1","first-page":"314","article-title":"B\u2010Cell non\u2010Hodgkin's lymphoma in children and adolescents: Surface antigen expression and clinical implications for future targeted bioimmune therapy: A children's cancer group report","volume":"1","author":"Perkins SL","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06689.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1275"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90175-2"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181c74aca"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.07.002"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.154.4.1249"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181c29c3c"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00035.2007"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP3FEPX5BEEKGX"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2013.00009"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22209"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.01.076"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81025-9"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0890"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3200293"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.v5.i2-3.60"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12711"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-381988"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.03.040"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.15.5363-5369.2000"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-351932"},{"key":"e_1_2_7_41_1","first-page":"85","article-title":"Evaluating antigen targeting and anti\u2010tumor activity of a new anti\u2010CD37 radioimmunoconjugate against non\u2010Hodgkin's lymphoma","volume":"33","author":"Dahle J","year":"2013","journal-title":"Anticancer Res"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0839"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-062927"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(03)00400-1"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512137"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-505685"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.32"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2569"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-413286"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-136473"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-081398"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0608352"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-264960"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-421057"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.01.009"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27314"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0129"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25193","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.25193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T13:45:20Z","timestamp":1696340720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,23]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1002\/pbc.25193"],"URL":"https:\/\/doi.org\/10.1002\/pbc.25193","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,23]]}}}